Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.48 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.48 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6929250 | 0.92 | POLB (0.59) | LMNAALDH1A1RECQLPOLBGAA | |
| SCHEMBL892987 | 0.84 | LMNA (1.00) | LMNAALDH1A1CHRM2CHRM4CHRM5 | |
| SCHEMBL1745361 | 0.82 | ALDH1A1 (0.66) | LMNAALDH1A1RECQLPOLBGAA | |
| SCHEMBL27486201 | 0.81 | POLB (0.50) | LMNAALDH1A1RECQLPOLBGAA | |
| SCHEMBL21192307 | 0.81 | POLB (0.50) | LMNAALDH1A1RECQLPOLBGAA | |
| SCHEMBL12374731 | 0.81 | ALDH1A1 (0.50) | LMNAALDH1A1RECQLPOLBGAA | |
| SCHEMBL17392944 | 0.81 | POLB (0.50) | LMNAALDH1A1RECQLPOLBGAA | |
| SCHEMBL3274800 | 0.81 | POLB (0.50) | LMNAALDH1A1RECQLPOLBGAA | |
| SCHEMBL1469845 | 0.81 | POLB (0.59) | LMNAALDH1A1RECQLPOLBGAA | |
| Hydrochloric Acid SCHEMBL6081619 | 0.81 | LMNA (0.93) | LMNAALDH1A1CHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1017395-A4 | METHOD FOR TREATING PREMENSTRUAL OR LATE LUTEAL PHASE SYNDROME | MERCK & CO INC (US) | 2003-06-04 | — | — | EP | disclosed |
| EP-1017395-A1 | METHOD FOR TREATING PREMENSTRUAL OR LATE LUTEAL PHASE SYNDROME | Merck & Co., Inc. (US) | 2000-07-12 | — | — | EP | disclosed |
| EP-1001780-A1 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING MANIA | MERCK SHARP & DOHME LTD. (GB) | 2000-05-24 | — | — | EP | disclosed |
| EP-1001779-A1 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING AGGRESSIVE BEHAVIOUR DISORDERS | MERCK SHARP & DOHME LTD. (GB) | 2000-05-24 | — | — | EP | disclosed |
| EP-0977572-A1 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING EATING DISORDERS | MERCK SHARP & DOHME LTD. (GB) | 2000-02-09 | — | — | EP | disclosed |
| EP-0977573-A1 | USE OF AN NK-1 RECEPTOR ANTAGONIST AND AN SSRI FOR TREATING OBESITY | MERCK SHARP & DOHME LTD. (GB) | 2000-02-09 | — | — | EP | disclosed |
| EP-0929303-A2 | CNS-PENETRANT NK-1 RECEPTOR ANTAGONISTS AS ANTIDEPRESSANT AND/OR AN ANTI-ANXIETY AGENT | MERCK SHARP & DOHME LTD. (GB) | 1999-07-21 | — | — | EP | disclosed |
| WO-1999009987-A1 | METHOD FOR TREATING PREMENSTRUAL OR LATE LUTEAL PHASE SYNDROME | MERCK & CO., INC. (US) | 1999-03-04 | — | — | WO | disclosed |
| WO-1999007374-A1 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING AGGRESSIVE BEHAVIOUR | MERCK SHARP & DOHME LIMITED (GB) | 1999-02-18 | — | — | WO | disclosed |
| WO-1999007376-A1 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING MANIA | MERCK SHARP & DOHME LIMITED (GB) | 1999-02-18 | — | — | WO | disclosed |
| WO-1999007375-A1 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING AGGRESSIVE BEHAVIOUR DISORDERS | MERCK SHARP & DOHME LIMITED (GB) | 1999-02-18 | — | — | WO | disclosed |
| WO-1998047514-A1 | USE OF AN NK-1 RECEPTOR ANTAGONIST AND AN SSRI FOR TREATING OBESITY | MERCK SHARP & DOHME LIMITED (GB) | 1998-10-29 | — | — | WO | disclosed |
| WO-1998047513-A1 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING EATING DISORDERS | MERCK SHARP & DOHME LIMITED (GB) | 1998-10-29 | — | — | WO | disclosed |
| WO-1998015277-A2 | CNS-PENETRANT NK-1 RECEPTOR ANTAGONISTS AS ANTIDEPRESSANT AND/OR AN ANTI-ANXIETY AGENTS | MERCK SHARP & DOHME LIMITED (GB) | 1998-04-16 | — | — | WO | disclosed |